RNA-seq of prostate cancer Patient‐Derived Xenografts derived from primary and metastatic tumors at different stages of progression

ABSTRACT: Patient-Derived Xenografts from primary (PNPCa) and metastatic (LuCaP series) prostate tumors have been implanted in immunocompromised mice and then subjected to PolyA+ RNA-sequencing.

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Homo sapiens

SUBMITTER: Marco Bolis 

PROVIDER: E-MTAB-9656 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress